KBC Group’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$61K Hold
4,560
– – ﹤0.01% 1654
2026
Q2
$68K Hold
4,560
– – ﹤0.01% 1601
2026
Q1
$39K Hold
4,560
– – ﹤0.01% 1727
2025
Q4
$51K Hold
4,560
– – ﹤0.01% 1631
2025
Q3
$68K Hold
4,560
– – ﹤0.01% 1501
2025
Q2
$64K Hold
4,560
– – ﹤0.01% 1471
2025
Q1
$110K Buy
4,560
+1,183
+35% +$41.7K ﹤0.01% 1424
2024
Q4
$126K Buy
3,377
+1,127
+50% +$52.6K ﹤0.01% 1395
2024
Q3
$112K Buy
2,250
+443
+25% +$17.2K ﹤0.01% 1212
2024
Q2
$63K Hold
1,807
– – ﹤0.01% 1472
2024
Q1
$99K Buy
1,807
+83
+5% +$4.11K ﹤0.01% 1128
2023
Q4
$74K Buy
1,724
+693
+67% +$21.6K ﹤0.01% 1252
2023
Q3
$27K Buy
+1,031
New +$21.4K ﹤0.01% 1826

Other funds holding BHVN

KBC Group's BHVN Position: Q3 2026 in Review

KBC Group held its Biohaven (BHVN) position steady in Q3 2026 at 4,560 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #1654.

KBC Group first reported a position in BHVN in Q3 2023 and has held it in 13 quarters since. The position peaked at $126K in Q4 2024. 65 funds tracked by Wall St. Rank hold BHVN as of Q3 2026.

  • KBC Group held 4,560 shares of Biohaven worth $61K as of Q3 2026.
  • KBC Group left its Biohaven share count unchanged in Q3 2026.
  • Biohaven made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1654 holding.
  • KBC Group first reported a position in Biohaven in Q3 2023 and has held it in 13 quarters since.
  • KBC Group's Biohaven position peaked at $126K in Q4 2024.
  • 65 funds tracked by Wall St. Rank held Biohaven as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.